Advanced Biotherapy Concepts Inc. Announces OTCBB Listing.Business Editors/Health & Medical Writers WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Feb. 22, 2000 Advanced Biotherapy biotherapy /bio·ther·a·py/ (-ther´ah-pe) biological therapy. bi·o·ther·a·py n. Treatment of disease with biologicals, such as vaccines. Concepts Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ADVB ADVB Associação dos Dirigentes de Vendas e Marketing do Brasil ) today announced that the company's shares are eligible for quotation on the OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. . The company completed its annual and quarterly Securities and Exchange Commission ("SEC") filings for the periods ending Sept. 30, 1999, as required by the NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). and is now current in its Securities Exchange Act of 1934 SEC reporting requirements. The company stated that on Feb. 15, 2000, the NASD approved its securities for quotation by NASD member firms. "We are pleased to have successfully completed the SEC review of our filing and to be listed on the OTCBB. As a fully reporting company, our stockholders will benefit from having current access to information regarding the company. It also allows us to be better positioned in moving the company's drug-development programs towards commercialization," stated Edmond Buccellato, chief executive officer of ADVB. Advanced Biotherapy Concepts is a development-stage biotechnology company developing treatments for severe autoimmune diseases including rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus Systemic Lupus Erythematosus Definition Systemic lupus erythematosus (also called lupus or SLE) is a disease where a person's immune system attacks and injures the body's own organs and tissues. Almost every system of the body can be affected by SLE. , insulin dependent diabetes and AIDS. The company's patented and proprietary treatment, which has been evaluated in approximately 150 patients, neutralizes certain cytokines Cytokines Chemicals made by the cells that act on other cells to stimulate or inhibit their function. Cytokines that stimulate growth are called "growth factors. now confirmed to be responsible for causing these diseases. Statements made in this news release, other than statements of historical fact, are forward-looking statements and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made, including risks associated with the success of clinical trials, the progress of research and product development programs, the regulatory approval process, competitive products, future capital requirements and the extent and breadth of the company's patent portfolio. See the company's public filing with the Securities and Exchange Commission for information about risks that may affect the company. |
|
|||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion